Workflow
Benzinga
icon
Search documents
Top 2 Real Estate Stocks Which Could Rescue Your Portfolio In July
Benzinga· 2025-07-03 12:04
Group 1 - The real estate sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] - An asset is considered oversold when the Relative Strength Index (RSI) is below 30, indicating potential short-term performance improvement [1] Group 2 - MacKenzie Realty Capital Inc (MKZR) reported a third-quarter loss of $0.47 per share, compared to a loss of $0.26 per share a year ago, with an RSI value of 24.5 [6] - The stock of MacKenzie Realty Capital fell approximately 26% over the past month, closing at $0.64, with a 52-week low of $0.60 [6] - La Rosa Holdings (LRHC) announced an 80-for-1 reverse stock split, with an RSI value of 17.6, and its stock fell around 43% over the past five days, closing at $0.080 [6]
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga· 2025-07-03 12:03
Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: Stock Ratings and Analyst Insights - Pfizer Inc. (PFE) has a dividend yield of 6.79%. Guggenheim analyst Vamil Divan reiterated a Buy rating with a 73% accuracy rate. Citigroup analyst Andrew Baum maintained a Neutral rating and reduced the price target from $30 to $29, with a 69% accuracy rate [7] - CVS Health Corporation (CVS) has a dividend yield of 3.99%. Truist Securities analyst David Macdonald maintained a Buy rating and raised the price target from $82 to $84, with a 67% accuracy rate. RBC Capital analyst Ben Hendrix maintained an Outperform rating and increased the price target from $74 to $81, with a 61% accuracy rate [7] - Merck & Co., Inc. (MRK) has a dividend yield of 3.93%. Citigroup analyst Andrew Baum downgraded the stock from Buy to Neutral and cut the price target from $115 to $84, with a 69% accuracy rate. Guggenheim analyst Vamil Divan reiterated a Buy rating with a price target of $115, maintaining a 73% accuracy rate [7] Group 2: Recent News - Pfizer announced positive topline Phase 3 results for HYMPAVZI™ in Hemophilia A or B with inhibitors on June 26 [7] - CVS Health will hold a conference call on July 31 to discuss second quarter 2025 financial results [7] - The FDA accepted and granted priority review for Merck's new supplemental Biologics License Application for Winrevair based on the Phase 3 ZENITH trial on July 2 [7]
OpenAI Says Tokens Are Not Equity, No Partnership With Robinhood: Musk Says AI Company's Equity 'Is Fake'
Benzinga· 2025-07-02 22:38
Core Viewpoint - OpenAI has clarified that the "OpenAI tokens" offered by Robinhood are not actual equity of OpenAI and that there is no partnership or involvement between the two companies regarding this product [1][2]. Group 1: OpenAI's Position - OpenAI stated that any transfer of its equity requires company approval, which was not granted in the case of the tokens offered by Robinhood [1][2]. - The company advised users to exercise caution regarding the tokens, emphasizing that they do not endorse or support the product [2]. Group 2: Robinhood's Initiative - Robinhood announced the launch of tokenized shares as part of a broader initiative involving tokenized equities, staking, and blockchain infrastructure [3]. - A spokesperson from Robinhood mentioned that these tokens provide retail investors with indirect exposure to private markets, facilitated by Robinhood's ownership stake in a special purpose vehicle [3]. Group 3: Market Reactions - Following the announcement of the tokenized shares, Robinhood's stock reached a new all-time high, reflecting positive market sentiment [4]. - KeyBanc Capital Markets raised its price target for Robinhood's stock from $60 to $110, citing innovation and total addressable market (TAM) expansion as key drivers for the upgrade [5]. - Despite the positive outlook, Robinhood shares experienced a slight decline of 1.71% to $96.30 in extended trading on Wednesday [5].
Lucid Reports Q2 Production, Delivery Numbers, Shares Stall
Benzinga· 2025-07-02 21:03
Production and Delivery Performance - Lucid Group Inc produced 3,863 vehicles in the second quarter, an increase from 2,212 vehicles in the first quarter [1] - Total second-quarter deliveries were 3,309 vehicles, up from 3,109 in the first quarter, but below analyst estimates of 3,611 [1] Financial Expectations - The company is scheduled to report its second-quarter financial results on August 5, with analysts expecting a loss of $0.21 per share and revenue of $297.06 million [2] - In the first quarter, Lucid reported revenue of $235.05 million, which was below estimates of $250 million, and a loss of $0.20 per share, better than the expected loss of $0.23 per share [2] Liquidity and Future Production Goals - Lucid ended the quarter with approximately $5.76 billion in total liquidity and indicated that momentum continued to build during the period [3] - The company is targeting total production of approximately 20,000 vehicles by 2025 [3] Stock Performance - Lucid shares closed at $2.05, up 0.99% on Wednesday, and remained flat in after-hours trading despite missing delivery estimates [3] - The stock has decreased approximately 32% year-to-date [3]
BYD Isn't Tesla's Only Asian Threat — This EV Maker Is Smashing Records
Benzinga· 2025-07-02 21:03
Core Viewpoint - Tesla is experiencing declining demand for its vehicles in the United States due to increased competition from foreign automakers, particularly Hyundai, which is gaining market share in the electric vehicle (EV) segment [1][2][8] Group 1: Tesla's Performance - Tesla reported second-quarter deliveries of 384,122 units, reflecting a 13.5% decrease year-over-year [1] - In 2024, Tesla had the two top-selling EVs in the U.S., but faced challenges as Hyundai's Ioniq 5 became the fourth-best-selling EV with 44,400 units sold, marking a 30.9% increase year-over-year [6] Group 2: Hyundai's Growth - Hyundai achieved record sales in the U.S. with 439,280 vehicles sold in the first half of 2025, representing a 10% increase year-over-year [2][3] - The Ioniq 5 EV had sales of 19,092 units in the first half of the year, up 2% year-over-year, while the Ioniq 9 began deliveries in May with 1,013 units sold [4] - Hyundai's U.S. EV market share reached 4.7% in 2024, trailing only Tesla (48.7%), Ford (7.5%), and Chevrolet (5.2%) [7] Group 3: Competitive Strategies - Hyundai's new EV plant in Georgia has the capacity to produce up to 300,000 vehicles annually, with potential expansion to 500,000 units [4] - The company has been reducing lease prices for the Ioniq 5, making it one of the most affordable EVs on the market, with deals starting at $170 per month [5] - Hyundai's increasing lineup of American-made vehicles and new marketing campaigns are contributing to its growing momentum in the EV market [4][8]
Stock Of The Day: Short Squeeze In BigBear.ai?
Benzinga· 2025-07-02 19:27
Group 1 - BigBear.ai Holdings, Inc. (BBAI) has experienced a significant and rapid stock rally, indicating a potential short squeeze [1][3] - Approximately 27% of BigBear's available shares have been loaned out, which is considerably high compared to the typical 1-2% for most stocks [3] - A short squeeze can lead to aggressive buying from short sellers, causing the stock price to rise further [4][6] Group 2 - The climax of a short squeeze occurs when lenders decide to sell their shares, forcing short sellers to buy back shares at any price [6] - Historical data shows that after a short squeeze, stocks can experience dramatic declines, as seen with BigBear's price drop of over 60% in February [7] - There is uncertainty regarding whether BigBear will experience a similar decline again after the current rally [7]
Quantum Computing's Dark Horse Rigetti Stands At The Edge Of Greatness
Benzinga· 2025-07-02 18:53
Core Viewpoint - Rigetti Computing has experienced a significant stock price increase of over 1,000% in the past year, attracting attention from Wall Street, particularly after Cantor Fitzgerald analyst Troy Jensen initiated coverage with an Overweight rating and a $15 price target [1][2]. Group 1: Market Position and Competitors - Rigetti is competing with major technology firms such as Alphabet Inc, IBM, Intel, and Microsoft, but the presence of these industry leaders is expected to facilitate advancements in quantum capabilities, benefiting Rigetti [3]. - The analyst highlighted that superconducting technology has received the most investment among the primary technologies capable of achieving quantum status [2]. Group 2: Strategic Partnerships - Rigetti's partnership with Quanta Computer is seen as a strategic move to accelerate the development and commercialization of superconducting quantum computing, with both companies committing to invest at least $250 million over five years [4]. - Quanta's investment of $35 million in Rigetti through a stock purchase in April is part of this collaboration, allowing Rigetti to focus on quantum technology while Quanta handles packaging and manufacturing [5]. Group 3: Financial Projections and Market Potential - Jensen projects that Rigetti could capture 15% of the quantum hardware, software, and services market by 2035, translating to a revenue present value of $477 million at a 10% discount rate [6]. - The analyst anticipates second-quarter revenue of $1.8 million and an EPS of $(0.06) for Rigetti [6]. - Despite a 22% year-to-date correction in Rigetti's stock price, this is viewed as an opportunity for investors to accumulate shares [6]. Group 4: Recent Stock Performance - Rigetti's stock price was reported at $12.52, reflecting a 10.4% increase as of the latest check [7].
App Store Fee Cuts Set To Boost Duolingo, Match, Bumble Earnings
Benzinga· 2025-07-02 18:49
Core Viewpoint - Recent legal challenges for Apple Inc. regarding alleged monopolistic practices and new App Store fee policies may positively impact subscription service companies like Duolingo, Match Group, and Bumble by reducing app store fees, which are a significant cost of revenue [1][2]. Financial Outlook - A reduction in app store fees could enhance earnings for Duolingo, Match Group, and Bumble, as these fees currently account for 17% of Duolingo's cost of revenues and 20% for both Match Group and Bumble [2][3]. - A 500 basis-point shift in subscription revenue to off-app payments could increase Duolingo's EBITDA by 3.3%, Match's by 2.8%, and Bumble's by 3.0%. Additionally, a 100 basis-point reduction in app store fees could raise their EBITDA by 3.2%, 2.7%, and 3.5%, respectively [4]. Price Forecast Adjustments - Price forecasts have been raised for Bumble to $5.50 from $5.25 and for Match Group to $34 from $32, while Duolingo's price forecast remains at $450 due to higher sector valuation [5]. Revenue Impact - The anticipated fee reduction is expected to result in a 1-2% increase in U.S.-based revenues for these companies, while the impact on EU-based revenues is estimated to be smaller, leading to only a 0.5% EBITDA increase [6]. Company-Specific Insights - Bumble is projected to benefit the most from a potential drop in U.S. app fees, supported by recent legal developments that allow developers to direct users to off-app payment options [7]. - Bumble, Duolingo, and Match are already testing off-app payments, with expectations for updates during the second-quarter earnings in August. A 500 basis-point shift to off-app payments and a 100 basis-point cut in U.S. app fees could boost Bumble's total EBITDA by 1.7% [8]. - Duolingo, Match, and Bumble derive only about 20% of their subscription revenue from the EU, limiting their earnings upside from EU app fee reductions due to DMA compliance [9].
Constellation Brands Navigates Soft Sales With Robust Beer Margins
Benzinga· 2025-07-02 18:09
Core Viewpoint - Constellation Brands, Inc. demonstrated resilience in its beer segment despite a slight dip in overall sales, allowing the company to reaffirm its full-year guidance amidst a challenging market [1][3]. Financial Performance - The company reported fiscal first-quarter earnings per share of $3.22, which was below the $3.30 consensus but above Bank of America’s estimate of $3.00, driven by stronger-than-expected beer gross margins and lower SG&A costs [2]. - Total sales were slightly below expectations due to softness in both beer and wine & spirits, but the company maintained its fiscal year guidance, which may raise skepticism given the weaker first-quarter trends [3]. Segment Analysis - The beer segment is expected to improve starting in the second quarter, aided by easier comparisons, although June scanner data indicated mid-single-digit declines [4]. - Depletions in the beer segment fell 2.6% year-over-year in the first quarter, slightly worse than Bank of America’s estimate but in line with consensus, while shipments declined by 3.3% [4]. Operational Insights - The quarter had one less selling day, negatively impacting shipment and depletion growth rates by more than 1%. No further selling day impacts are expected for the remainder of fiscal year 2026 [5]. - Gross margins in the beer segment exceeded forecasts at 53.1%, attributed to approximately $40 million in cost and operational efficiencies. Marketing spend was $201 million, lower than the estimated $220 million, and is expected to be concentrated in the first half of the fiscal year [5]. Wine & Spirits Performance - The Wine & Spirits segment underperformed with sales of $280.5 million, although operating losses of $6 million were better than anticipated [6]. Market Valuation - Bank of America analyst Peter T. Galbo maintained a Neutral rating on Constellation Brands with a price forecast of $180, reflecting a justified discount to their 5-year average due to ongoing challenges in the beer segment, including softer demand from Hispanic consumers and broader industry headwinds [6].
Cash-Rich IonQ To Capture 20% Of Quantum Market By 2035
Benzinga· 2025-07-02 17:56
Core Viewpoint - The quantum computing sector is gaining significant investor interest due to its long-term economic potential, leading to inflated stock valuations that exceed justifiable near-term revenue or earnings [1] Company Overview - IonQ, Inc. is recognized as a leader in the quantum computing field, with an Overweight rating initiated by Cantor Fitzgerald analyst Troy Jensen and a price target of $45 [1] Technology and Innovation - IonQ employs a trapped-ion approach that allows for room-temperature operations and strong performance, utilizing a scalable modular architecture that supports quantum networking [2] - The company aims to scale from 36 physical qubits in its Forte Enterprise system to 10,000 qubits on a single chip by 2027, and to 20,000 qubits by connecting two chips in 2028, supported by acquisitions like Lightsynq and Oxford Ionics [3] Financial Position - IonQ ended Q1 2025 with nearly $700 million in cash after a $373 million equity raise, positioning the company for aggressive product innovation, international growth, and strategic acquisitions [4] - The company has experienced a share price increase of approximately 511% over the past year and 3% year-to-date, indicating strong market performance [4] Market Potential - Jensen estimates that IonQ could capture 20% of the quantum computing market by 2035, translating to a present value of $636 million [5] - IonQ is strategically positioned at the intersection of quantum computing and networking, bolstered by acquisitions such as ID Quantique and Lightsynq [5] Growth and Partnerships - The company is advancing along a defined technical roadmap aimed at scalable commercial use, supported by a solid revenue momentum and a strong patent base [6] - IonQ's expanding partnerships with enterprises, government entities, and global partners further solidify its leadership in the emerging quantum sector [6] Stock Performance - IonQ shares have seen a recent increase of 5.29%, trading at $42.22 [6]